Analyst firms · Morgan Stanley · INSM
Morgan Stanley INSM price target and rating history
Insmed Incorporated (INSM) · Health Care
Morgan Stanley rates Insmed Incorporated (INSM) Overweight with a $212 price target, as of its latest action on Mar 30, 2026. It has published 3 rating actions on INSM since October 2021, including 1 upgrade and 1 downgrade. Across 9 firms with a INSM price target in the last 12 months, the median target is $212. Morgan Stanley's target matches it.
- Current rating
- Overweight
- Price target
- $212
- Median target, all firms
- $212
- Actions on INSM
- 3
Morgan Stanley price target on INSM
Every Morgan Stanley rating on INSM
- Mar 30, 2026
- Aug 13, 2025
- Oct 19, 2021
How other firms rate INSM
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| H.C. Wainwright | Buy | $220 | Nov 4, 2026 |
| Wolfe Research | Peer Perform | Oct 12, 2026 | |
| Goldman Sachs | Buy | $188 | Sep 24, 2026 |
| BMO Capital Markets | Outperform | $192 | Jul 21, 2026 |
| Raymond James | Outperform | $200 | Apr 10, 2026 |
| Morgan Stanley | Overweight | $212 | Mar 30, 2026 |
| Jefferies | Buy | Mar 16, 2026 | |
| Barclays | Overweight | $231 | Jan 28, 2026 |
| Roth Capital | Buy | $212 | Jan 23, 2026 |
| Truist Securities | Buy | $202 | Dec 19, 2025 |
| Rothschild & Co Redburn | Buy | $263 | Dec 4, 2025 |
Questions about Morgan Stanley and INSM
- What is Morgan Stanley's price target for INSM?
- Morgan Stanley's latest stated price target for Insmed Incorporated (INSM) is $212, from its action on Mar 30, 2026.
- What is Morgan Stanley's rating on INSM?
- Morgan Stanley rates INSM Overweight, a bullish rating, as of Mar 30, 2026.
- When did Morgan Stanley last change its view on INSM?
- On Mar 30, 2026, Morgan Stanley upgrades to Overweight from Equal-Weight, price target $212.
- How does Morgan Stanley's INSM target compare with other analysts?
- Across 9 firms with a INSM price target in the last 12 months, the median target is $212. Morgan Stanley's target matches it.
All Morgan Stanley ratingsINSM news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.